Skip to main content
Caplight Logo









JotPsych

JotPsych

Private
Brooklyn, New YorkHealthcare & Life Scienceshttps://jotpsych.com/

Last Round

Seed

Jul 29, 2025

Total Funding Raised

$5.31M

Momentum

Top 1%

of companies Caplight tracks

Company Overview

JotPsych is a healthtech company that provides an AI-powered clinical scribe and revenue cycle management platform for behavioral health clinicians.

Sector

Healthcare & Life Sciences

Verticals

Mental Health, Medical AI, NLP & Conversational AI, Vertical SaaS, Document Management

Business Model

B2B

Customer Profile

Subscription SaaS, Payment Processing Fee, Services & Consulting

AI Layer

Application

Keywords

AI scribeclinical documentationmental health softwaremedical scribeelectronic health recordEHRrevenue cycle managementRCMpractice management softwarevertical SaaSAI medical scribeautomated chartingclinical note automationtelehealth documentationmedical billing software

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

JotPsych Comparables

Compare JotPsych with similar companies based on industry and business-model similarity.

JotPsych comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Berries
94%
Mentalyc
93%
PMHScribe
93%

JotPsych Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJul 29, 2025

Key People

Founding team and executive leadership

Jackson Bierfeldt

CTO, Co-Founder

Founding Team

Nathan Peereboom

CEO, Co-Founder

Founding Team

JotPsych Investors

Notable investors and investment history

JotPsych investors
InvestorRounds
Coelius CapitalSeed
Base10 PartnersSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 1, 2026

    Open roles increased to 402, 1675% of headcount.

  • Aug 24, 2026

    Open roles increased to 297, 4.6x the trailing average.

Recent news

Latest coverage and updates

  • identified_as_competitor_ofAug 19, 2026

    JotPsych identified as competitor of Scribenote Inc..

JotPsych Filings

Explore SEC and related filing metadata, where available.

JotPsych filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about JotPsych's valuation, stock price, and market status.

Is JotPsych a public or private company?

JotPsych is a private company.

What is the current stock price of JotPsych?

JotPsych is a private company with no public stock price. No recent secondary market data is available.

How much is JotPsych worth (valuation)?

Valuation information for JotPsych is not publicly available.

Can I buy JotPsych stock?

JotPsych shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was JotPsych's last funding round?

JotPsych's most recent funding round was Seed on July 29, 2025.

Who are the main investors in JotPsych?

Key investors in JotPsych include Base10 Partners.

Will JotPsych IPO soon?

No public IPO plans have been announced for JotPsych.

How can I track JotPsych secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor JotPsych's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBrooklyn, New York
Employee Range18
Year Founded2023
Last FundingJul 29, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?